Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-04-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-025-01274-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850183990898589696 |
|---|---|
| author | Christina Rautenberg Jan Moritz Middeke Christoph Röllig Matthias Stelljes Verena Gaidzik Oliver Kriege Mareike Verbeek Katrin Koch Julia Marie Unglaub Felicitas Thol Stefan W. Krause Mathias Hänel Charlotte Neuerburg Vladan Vucinic Christian-Friedrich Jehn Maxi Wass Michael Heuser Lars Fransecky Jens Chemnitz Udo Holtick Kerstin Schäfer-Eckart Josephine Schröder Sabrina Kraus William Krüger Ulrich Kaiser Sebastian Scholl Guido Kobbe Paul Sebastian Jäger Nael Alakel Malte von Bonin Katja Sockel Maher Hanoun Uwe Platzbecker Tobias A. W. Holderried Anke Morgner Tim Sauer Katharina S. Götze Eva Wagner-Drouet Konstanze Döhner Hartmut Döhner Christoph Schliemann Johannes Schetelig Martin Bornhäuser Ulrich Germing Sara Flossdorf Thomas Schroeder Friedrich Stölzel |
| author_facet | Christina Rautenberg Jan Moritz Middeke Christoph Röllig Matthias Stelljes Verena Gaidzik Oliver Kriege Mareike Verbeek Katrin Koch Julia Marie Unglaub Felicitas Thol Stefan W. Krause Mathias Hänel Charlotte Neuerburg Vladan Vucinic Christian-Friedrich Jehn Maxi Wass Michael Heuser Lars Fransecky Jens Chemnitz Udo Holtick Kerstin Schäfer-Eckart Josephine Schröder Sabrina Kraus William Krüger Ulrich Kaiser Sebastian Scholl Guido Kobbe Paul Sebastian Jäger Nael Alakel Malte von Bonin Katja Sockel Maher Hanoun Uwe Platzbecker Tobias A. W. Holderried Anke Morgner Tim Sauer Katharina S. Götze Eva Wagner-Drouet Konstanze Döhner Hartmut Döhner Christoph Schliemann Johannes Schetelig Martin Bornhäuser Ulrich Germing Sara Flossdorf Thomas Schroeder Friedrich Stölzel |
| author_sort | Christina Rautenberg |
| collection | DOAJ |
| format | Article |
| id | doaj-art-a7a8bc74c548467cb5cb90ce5e2021cb |
| institution | OA Journals |
| issn | 2044-5385 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Blood Cancer Journal |
| spelling | doaj-art-a7a8bc74c548467cb5cb90ce5e2021cb2025-08-20T02:17:09ZengNature Publishing GroupBlood Cancer Journal2044-53852025-04-011511410.1038/s41408-025-01274-0Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patientsChristina Rautenberg0Jan Moritz Middeke1Christoph Röllig2Matthias Stelljes3Verena Gaidzik4Oliver Kriege5Mareike Verbeek6Katrin Koch7Julia Marie Unglaub8Felicitas Thol9Stefan W. Krause10Mathias Hänel11Charlotte Neuerburg12Vladan Vucinic13Christian-Friedrich Jehn14Maxi Wass15Michael Heuser16Lars Fransecky17Jens Chemnitz18Udo Holtick19Kerstin Schäfer-Eckart20Josephine Schröder21Sabrina Kraus22William Krüger23Ulrich Kaiser24Sebastian Scholl25Guido Kobbe26Paul Sebastian Jäger27Nael Alakel28Malte von Bonin29Katja Sockel30Maher Hanoun31Uwe Platzbecker32Tobias A. W. Holderried33Anke Morgner34Tim Sauer35Katharina S. Götze36Eva Wagner-Drouet37Konstanze Döhner38Hartmut Döhner39Christoph Schliemann40Johannes Schetelig41Martin Bornhäuser42Ulrich Germing43Sara Flossdorf44Thomas Schroeder45Friedrich Stölzel46Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital EssenMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University DresdenMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University DresdenDepartment of Medicine A, University Hospital MünsterDepartment of Internal Medicine III, University Hospital of UlmDepartment of Medicine III, University Medical Center, Johannes Gutenberg University MainzDepartment of Medicine III, Technical University of MunichDepartment of Medicine III, Technical University of MunichDepartment of Internal Medicine V, University Hospital HeidelbergDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical SchoolDepartment 5 for Internal Medicine, University Hospital ErlangenDepartment of Internal Medicine III, Chemnitz HospitalDepartment of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital BonnDepartment of Hematology, Cellular Therapy, Hemostaseology and Infectious DiseasesDepartment of Hematology, Oncology and Stem Cell Transplantation, Asklepios Clinic St. GeorgDepartment of Hematology, Oncology and Stem Cell Transplantation, Asklepios Clinic St. GeorgDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical SchoolDivision of Stem Cell Transplantation and Cellular Imunotherapies, Department of Hematology and Oncology, University Hospital Schleswig-HolsteinGemeinschaftsklinikum Mittelrhein GGmbHDepartment I of Internal Medicine, University Hospital of CologneDepartment of Internal Medicine V, Oncology and Hematology, Klinikum NürnbergClinic for Hematology and Stem Cell Transplantation HELIOS Clinic Berlin-Buch GmbHDivision of Hematology and Oncology, Department of Internal Medicine II, University of Würzburg, Medical CenterClinic and Policlinic for Internal Medicine C, Hematology and Oncology, University of GreifswaldDepartment of Hematology and Oncology, St. Bernward KrankenhausDepartment of Internal Medicine II, Hematology and Oncology, University Hospital JenaDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine – UniversityDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine – UniversityMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University DresdenMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University DresdenMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University DresdenDepartment of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital EssenDepartment of Hematology, Cellular Therapy, Hemostaseology and Infectious DiseasesDepartment of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital BonnDepartment of Internal Medicine III, Chemnitz HospitalDepartment of Internal Medicine V, University Hospital HeidelbergDepartment of Medicine III, Technical University of MunichDepartment of Medicine III, University Medical Center, Johannes Gutenberg University MainzDepartment of Internal Medicine III, University Hospital of UlmDepartment of Internal Medicine III, University Hospital of UlmDepartment of Medicine A, University Hospital MünsterMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University DresdenMedizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University DresdenDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine – UniversityDepartment for Medical Informatics, Biometry and Epidemiology, University Hospital EssenDepartment of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital EssenDivision of Stem Cell Transplantation and Cellular Imunotherapies, Department of Hematology and Oncology, University Hospital Schleswig-Holsteinhttps://doi.org/10.1038/s41408-025-01274-0 |
| spellingShingle | Christina Rautenberg Jan Moritz Middeke Christoph Röllig Matthias Stelljes Verena Gaidzik Oliver Kriege Mareike Verbeek Katrin Koch Julia Marie Unglaub Felicitas Thol Stefan W. Krause Mathias Hänel Charlotte Neuerburg Vladan Vucinic Christian-Friedrich Jehn Maxi Wass Michael Heuser Lars Fransecky Jens Chemnitz Udo Holtick Kerstin Schäfer-Eckart Josephine Schröder Sabrina Kraus William Krüger Ulrich Kaiser Sebastian Scholl Guido Kobbe Paul Sebastian Jäger Nael Alakel Malte von Bonin Katja Sockel Maher Hanoun Uwe Platzbecker Tobias A. W. Holderried Anke Morgner Tim Sauer Katharina S. Götze Eva Wagner-Drouet Konstanze Döhner Hartmut Döhner Christoph Schliemann Johannes Schetelig Martin Bornhäuser Ulrich Germing Sara Flossdorf Thomas Schroeder Friedrich Stölzel Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients Blood Cancer Journal |
| title | Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients |
| title_full | Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients |
| title_fullStr | Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients |
| title_full_unstemmed | Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients |
| title_short | Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients |
| title_sort | real world experience with first line cpx 351 treatment in patients with acute myeloid leukemia long term follow up with focus on younger patients |
| url | https://doi.org/10.1038/s41408-025-01274-0 |
| work_keys_str_mv | AT christinarautenberg realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT janmoritzmiddeke realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT christophrollig realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT matthiasstelljes realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT verenagaidzik realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT oliverkriege realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT mareikeverbeek realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT katrinkoch realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT juliamarieunglaub realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT felicitasthol realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT stefanwkrause realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT mathiashanel realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT charlotteneuerburg realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT vladanvucinic realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT christianfriedrichjehn realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT maxiwass realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT michaelheuser realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT larsfransecky realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT jenschemnitz realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT udoholtick realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT kerstinschafereckart realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT josephineschroder realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT sabrinakraus realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT williamkruger realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT ulrichkaiser realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT sebastianscholl realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT guidokobbe realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT paulsebastianjager realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT naelalakel realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT maltevonbonin realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT katjasockel realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT maherhanoun realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT uweplatzbecker realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT tobiasawholderried realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT ankemorgner realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT timsauer realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT katharinasgotze realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT evawagnerdrouet realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT konstanzedohner realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT hartmutdohner realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT christophschliemann realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT johannesschetelig realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT martinbornhauser realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT ulrichgerming realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT saraflossdorf realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT thomasschroeder realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients AT friedrichstolzel realworldexperiencewithfirstlinecpx351treatmentinpatientswithacutemyeloidleukemialongtermfollowupwithfocusonyoungerpatients |